Literature DB >> 7703489

Platelet adhesion and aggregation on human type VI collagen surfaces under physiological flow conditions.

J M Ross1, L V McIntire, J L Moake, J H Rand.   

Abstract

Type VI collagen is a subendothelial constituent that binds von Willebrand factor (vWF) and platelets. The interaction of platelets with type VI collagen and the roles of platelet glycoprotein (GP) receptors and vWF were studied under flow conditions using epi-fluorescent videomicroscopy coupled with digital image processing. We found that surface coverage was less than 6% on collagen VI at a relatively high-wall shear rate (1,000 s-1) and was approximately 60% at a low-wall shear rate (100 s-1). The molecular mechanisms involved in low-shear platelet binding were studied using monoclonal antibodies to platelet GPIb and GPIIb-IIIa, and polymeric aurin tricarboxylic acid. Anti-GPIIb-IIIa was the most effective in eliminating adhesion (surface coverage, 0.8%), followed by anti-GPIb (4.3%), and ATA (12.6%). Experiments with von Willebrand disease blood indicate that vWF is involved in platelet adhesion to collagen VI at 100 s-1. In the absence of vWF, there may be direct binding of platelet GPIIb-IIIa complexes to collagen VI. Adhesion and aggregation on collagen VI are different in shear rate dependence from collagen I. Our results suggest a possible role for collagen VI and vWF in platelet adhesion and aggregation in vascular regions with low shear rates.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7703489

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Critical von Willebrand factor A1 domain residues influence type VI collagen binding.

Authors:  V H Flood; J C Gill; P A Christopherson; D B Bellissimo; K D Friedman; S L Haberichter; S R Lentz; R R Montgomery
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

2.  A membrane-based microfluidic device for controlling the flux of platelet agonists into flowing blood.

Authors:  Keith B Neeves; Scott L Diamond
Journal:  Lab Chip       Date:  2008-04-03       Impact factor: 6.799

3.  The role of fibrinogen spacing and patch size on platelet adhesion under flow.

Authors:  Aurore B Van de Walle; Jeffrey Fontenot; Travis G Spain; Daniel B Brunski; Ernest S Sanchez; Joel C Keay; Mark E Curtis; Matthew B Johnson; Trevor A Snyder; David W Schmidtke
Journal:  Acta Biomater       Date:  2012-07-20       Impact factor: 8.947

4.  von Willebrand factor binds to native collagen VI primarily via its A1 domain.

Authors:  M F Hoylaerts; H Yamamoto; K Nuyts; I Vreys; H Deckmyn; J Vermylen
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

5.  Matrix protein microarrays for spatially and compositionally controlled microspot thrombosis under laminar flow.

Authors:  Uzoma M Okorie; Scott L Diamond
Journal:  Biophys J       Date:  2006-08-11       Impact factor: 4.033

6.  Functional analysis of the Staphylococcus aureus collagen adhesin B domain.

Authors:  J L Snodgrass; N Mohamed; J M Ross; S Sau; C Y Lee; M S Smeltzer
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Identification of extant vertebrate Myxine glutinosa VWF: evolutionary conservation of primary hemostasis.

Authors:  Marianne A Grant; David L Beeler; Katherine C Spokes; Junmei Chen; Harita Dharaneeswaran; Tracey E Sciuto; Ann M Dvorak; Gianluca Interlandi; José A Lopez; William C Aird
Journal:  Blood       Date:  2017-09-12       Impact factor: 22.113

8.  Inhibition of Staphylococcus aureus adherence to collagen under dynamic conditions.

Authors:  N Mohamed; M A Teeters; J M Patti; M Höök; J M Ross
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

9.  Systems biology approach to the dissection of the complexity of regulatory networks in the S. scrofa cardiocirculatory system.

Authors:  Paolo Martini; Gabriele Sales; Enrica Calura; Mattia Brugiolo; Gerolamo Lanfranchi; Chiara Romualdi; Stefano Cagnin
Journal:  Int J Mol Sci       Date:  2013-11-21       Impact factor: 5.923

10.  Combined effects of two mutations in von Willebrand disease 2M phenotype.

Authors:  Adriana I Woods; Juvenal Paiva; Ana C Kempfer; Debora M Primrose; Alicia N Blanco; Analía Sanchez-Luceros; María A Lazzari
Journal:  Res Pract Thromb Haemost       Date:  2017-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.